Iridex (IRIX) Cash from Operations Growth (1y) (2012 - 2026)
Iridex (IRIX) Cash from Operations Growth (1y) (2012 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Ops. Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.85 Bn | 176.55 Bn | 6.27 Bn | -7.20% |
| 2 | Stryker | 128.90 Bn | 126.02 Bn | 3.81 Bn | 132.40% |
| 3 | Medtronic | 108.55 Bn | 99.33 Bn | 6.41 Bn | 1.78% |
| 4 | Boston Scientific | 68.56 Bn | 67.10 Bn | 3.61 Bn | -35.67% |
| 5 | Edwards Lifesciences | 48.24 Bn | 44.57 Bn | 1.29 Bn | -84.38% |
| 6 | Dexcom | 28.40 Bn | 27.28 Bn | 750.30 Mn | 185.96% |
| 7 | GE HealthCare Technologies | 28.15 Bn | 25.87 Bn | 1.98 Bn | 16.00% |
| 8 | Smith & Nephew | 26.89 Bn | 26.31 Bn | - | - |
| 9 | Koninklijke Philips | 24.75 Bn | 21.63 Bn | 2.07 Bn | 122.43% |
| 10 | Iridex | 15.45 Mn | 10.86 Mn | 4.74 Mn | -16.19% |
Historic Data
Download Data| Date | Value |
|---|---|
| Apr 4, 2026 | -16.19% |
| Jan 3, 2026 | 147.58% |
| Sep 27, 2025 | 62.32% |
| Jun 28, 2025 | 70.06% |
| Mar 29, 2025 | 30.28% |
| Dec 28, 2024 | -26.46% |
| Sep 28, 2024 | -72.45% |
| Jun 29, 2024 | -16.21% |
| Mar 30, 2024 | 42.03% |
| Dec 30, 2023 | 38.43% |
| Sep 30, 2023 | 15.38% |
| Jul 1, 2023 | 55.60% |
| Apr 1, 2023 | 12.60% |
| Dec 31, 2022 | -114.14% |
| Apr 2, 2022 | -127.50% |
| Apr 3, 2021 | 914.18% |
| Sep 26, 2020 | 116.00% |
| Jun 27, 2020 | -45.60% |
| Mar 28, 2020 | 61.73% |
| Dec 28, 2019 | 90.78% |